Institute for Safe Medicine Practices issues Paxlovid guide after several errors reported

After the FDA reported dozens of pharmaceutical issues involved with Paxlovid, an antiviral treatment for mild-to-moderate COVID-19 symptoms, the Institute for Safe Medication Practices updated its safe practice list for pharmacists June 30. 

Advertisement

4 things to know: 

1. Double check the emergency health record or prescribing system to ensure the correct dosage. Before prescribing, refer to the FDA’s Paxlovid checklist for patient eligibility. 

2. Don’t prescribe the treatment to patients with severe renal failure. Paxlovid is authorized for moderate renal impairment. 

3. Avoid naming the regimen’s two pills, nirmatrelvir and ritonavir, by the packaging’s colors as this can lead to confusion. 

4. The institute recommended Pfizer change the packaging on the renal dosing cartons to better differentiate the treatment from other Paxlovid packs. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.